search
Documents
Potassium Clavulanate Ph. Eur Monograph
The Ph. Eur. Monograph 1140 outlines the separation of Potassium Clavulanate from Amoxicillin. This method was studied and improvements were made to provide faster separations within allowable adjustments.
Potassium Clavulanate Ph. Eur Monograph
The Ph. Eur. Monograph 1140 outlines the separation of Potassium Clavulanate from Amoxicillin. This method was studied and improvements were made to provide faster separations within allowable adjustments.
Document Type:
Technical Notes
Target Industries:
Techniques:
Separation Modes:
Reversed Phase
Phases:
Can't view? Disable your browser's pop-up blocker.
Potassium Clavulanate Ph. Eur Monograph
The Ph. Eur. Monograph 1140 outlines the separation of Potassium Clavulanate from Amoxicillin. This method was studied and improvements were made to provide faster separations within allowable adjustments.
| Target Industries: | Biopharmaceutical Analysis, Pharmaceutical |
| Techniques: | HPLC, HPLC Reversed Phase |
| Brands: | Gemini, Kinetex |
| Separation Modes: | Reversed Phase |
| Phases: | Gemini NX-C18, Kinetex C18 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide